VLDB 2026 Research / reviewers in the wild / expert
Liyun Jiang
dblp:290/0035
· DBLP profile ↗
2ranked-venue papers
0as first author
2since 2021 · last 2025
0000-0001-5625-7444ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 2 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › cancer genomics
cancer subtyping |
0.5 | 1 | 2021 | MOVICS: an R package for multi-omics integration and visualization in cancer subtyping · Bioinform. 2021 |
Bioinformatics and computational biology › multi-omics data integration
integrative clustering |
0.5 | 1 | 2021 | MOVICS: an R package for multi-omics integration and visualization in cancer subtyping · Bioinform. 2021 |
Bioinformatics and computational biology
multi-omics data integration |
0.5 | 1 | 2021 | MOVICS: an R package for multi-omics integration and visualization in cancer subtyping · Bioinform. 2021 |
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | Accounting for the impact of rare variants on causal inference with RARE: a novel multivariable Mendelian randomization methodabstractMendelian randomization (MR) method utilizes genetic variants as instrumental variables to infer the causal effect of an exposure on an outcome. However, the impact of rare variants on traits is often neglected, and traditional MR assumptions can be violated by correlated horizontal pleiotropy (CHP) and uncorrelated horizontal pleiotropy (UHP). To address these issues, we propose a multivariable MR approach, an extension of the standard MR framework: MVMR incorporating Rare variants Accounting for multiple Risk factors and shared horizontal plEiotropy (RARE). In the simulation studies, we demonstrate that RARE effectively detects the causal effects of exposures on outcome with accounting for the impact of rare variants on causal inference. Additionally, we apply RARE to study the effects of high density lipoprotein and low density lipoprotein on type 2 diabetes and coronary atherosclerosis, respectively, thereby illustrating its robustness and effectiveness in real data analysis. Xinjia Ruan, Xiaofan Lu, Shangjin Yan, Yuzhe Sun, Fangrong Yan, Liyun Jiang |
Briefings Bioinform. | 9 |
| 2021 | MOVICS: an R package for multi-omics integration and visualization in cancer subtypingabstractSUMMARY: Stratification of cancer patients into distinct molecular subgroups based on multi-omics data is an important issue in the context of precision medicine. Here, we present MOVICS, an R package for multi-omics integration and visualization in cancer subtyping. MOVICS provides a unified interface for 10 state-of-the-art multi-omics integrative clustering algorithms, and incorporates the most commonly used downstream analyses in cancer subtyping researches, including characterization and comparison of identified subtypes from multiple perspectives, and verification of subtypes in external cohort using two model-free approaches for multiclass prediction. MOVICS also creates feature rich customizable visualizations with minimal effort. By analysing two published breast cancer cohort, we signifies that MOVICS can serve a wide range of users and assist cancer therapy by moving away from the 'one-size-fits-all' approach to patient care. AVAILABILITY AND IMPLEMENTATION: MOVICS package and online tutorial are freely available at https://github.com/xlucpu/MOVICS. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Xiaofan Lu, Jialin Meng, Liyun Jiang, Fangrong Yan |
Bioinform. | 4 |